171 related articles for article (PubMed ID: 19494474)
1. The role of colesevelam HCl in type 2 diabetes mellitus therapy.
Handelsman Y
Postgrad Med; 2009 May; 121(3 Suppl 1):19-24. PubMed ID: 19494474
[TBL] [Abstract][Full Text] [Related]
2. The use of colesevelam HCl in patients with type 2 diabetes mellitus: combining glucose- and lipid-lowering effects.
Goldfine AB; Fonseca VA
Postgrad Med; 2009 May; 121(3 Suppl 1):13-8. PubMed ID: 19494473
[TBL] [Abstract][Full Text] [Related]
3. Colesevelam hydrochloride added to background metformin therapy in patients with type 2 diabetes mellitus: a pooled analysis from 3 clinical studies.
Bays HE
Endocr Pract; 2011; 17(6):933-8. PubMed ID: 21856592
[TBL] [Abstract][Full Text] [Related]
4. Expanded colesevelam administration options with oral suspension formulation for patients with diabetes and hypercholesterolemia.
Dayer-Berenson L; Finckenor M
Postgrad Med; 2014 May; 126(3):126-34. PubMed ID: 24918798
[TBL] [Abstract][Full Text] [Related]
5. The use of the bile acid sequestrant colesevelam HCl in patients with type 2 diabetes mellitus: for glucose and lipid control. Introduction.
Handelsman Y
Postgrad Med; 2009 May; 121(3 Suppl 1):5-6. PubMed ID: 19494471
[No Abstract] [Full Text] [Related]
6. Results of the glucose-lowering effect of WelChol study (GLOWS): a randomized, double-blind, placebo-controlled pilot study evaluating the effect of colesevelam hydrochloride on glycemic control in subjects with type 2 diabetes.
Zieve FJ; Kalin MF; Schwartz SL; Jones MR; Bailey WL
Clin Ther; 2007 Jan; 29(1):74-83. PubMed ID: 17379048
[TBL] [Abstract][Full Text] [Related]
7. A review of bile acid sequestrants: potential mechanism(s) for glucose-lowering effects in type 2 diabetes mellitus.
Staels B
Postgrad Med; 2009 May; 121(3 Suppl 1):25-30. PubMed ID: 19494475
[TBL] [Abstract][Full Text] [Related]
8. Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy.
Fonseca VA; Rosenstock J; Wang AC; Truitt KE; Jones MR
Diabetes Care; 2008 Aug; 31(8):1479-84. PubMed ID: 18458145
[TBL] [Abstract][Full Text] [Related]
9. An economic evaluation of colesevelam when added to metformin-, insulin- or sulfonylurea-based therapies in patients with uncontrolled type 2 diabetes mellitus.
Simons WR; Hagan MA
Pharmacoeconomics; 2010; 28(9):765-80. PubMed ID: 20799756
[TBL] [Abstract][Full Text] [Related]
10. Colesevelam hydrochloride to treat hypercholesterolemia and improve glycemia in prediabetes: a randomized, prospective study.
Handelsman Y; Goldberg RB; Garvey WT; Fonseca VA; Rosenstock J; Jones MR; Lai YL; Jin X; Misir S; Nagendran S; Abby SL
Endocr Pract; 2010; 16(4):617-28. PubMed ID: 20634176
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy of colesevelam in type 2 diabetes mellitus.
Brunetti L; Campbell RK
J Pharm Pract; 2011 Aug; 24(4):417-25. PubMed ID: 21813819
[TBL] [Abstract][Full Text] [Related]
12. Colesevelam hydrochloride therapy in patients with type 2 diabetes mellitus treated with metformin: glucose and lipid effects.
Bays HE; Goldberg RB; Truitt KE; Jones MR
Arch Intern Med; 2008 Oct; 168(18):1975-83. PubMed ID: 18852398
[TBL] [Abstract][Full Text] [Related]
13. Rationale and design of a prospective clinical trial program to evaluate the glucose-lowering effects of colesevelam HCl in patients with type 2 diabetes mellitus.
Bays HE; Cohen DE
Curr Med Res Opin; 2007 Jul; 23(7):1673-84. PubMed ID: 17588297
[TBL] [Abstract][Full Text] [Related]
14. The management of type 2 diabetes mellitus: a novel approach for addressing glycemic and lipid control with colesevelam HCl.
Wright WL
Adv Nurse Pract; 2009 Nov; 17(11):suppl 1-16. PubMed ID: 20014684
[No Abstract] [Full Text] [Related]
15. Concomitant reduction in low-density lipoprotein cholesterol and glycated hemoglobin with colesevelam hydrochloride in patients with type 2 diabetes: a pooled analysis.
Jialal I; Abby SL; Misir S; Nagendran S
Metab Syndr Relat Disord; 2009 Jun; 7(3):255-8. PubMed ID: 19344229
[TBL] [Abstract][Full Text] [Related]
16. Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetes.
Jones MR; Mudaliar S; Hernandez-Triana E; Unnikrishnan AG; Lai YL; Abby SL; Misir S; Jin X; Nagendran S
Curr Med Res Opin; 2009 Sep; 25(9):2239-49. PubMed ID: 19622007
[TBL] [Abstract][Full Text] [Related]
17. Glucose and low-density lipoprotein cholesterol lowering in elderly patients with type 2 diabetes: focus on combination therapy with colesevelam HCl.
Marrs JC
Drugs Aging; 2012 May; 29(5):e1-e12. PubMed ID: 22530704
[TBL] [Abstract][Full Text] [Related]
18. Review of studies on the effect of bile acid sequestrants in patients with type 2 diabetes mellitus.
Levy P
Metab Syndr Relat Disord; 2010 Dec; 8 Suppl 1():S9-13. PubMed ID: 20946010
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of colesevelam on lowering glycemia and lipids.
Aggarwal S; Loomba RS; Arora RR
J Cardiovasc Pharmacol; 2012 Feb; 59(2):198-205. PubMed ID: 21983746
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of colesevelam in patients with type 2 diabetes mellitus and inadequate glycemic control receiving insulin-based therapy.
Goldberg RB; Fonseca VA; Truitt KE; Jones MR
Arch Intern Med; 2008 Jul; 168(14):1531-40. PubMed ID: 18663165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
